Ketoconazole

酮康唑

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameKetoconazole
Drug Alias NameKetoconazolum酮康只唑金康肽宁Xolegel CorePakXolegel Duo +[18
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsHip FracturesCushing SyndromePsoriasis +[23
Global Approved IndicationsCushing SyndromeDermatitis, SeborrheicParacoccidioidomycosis +[12
Approved Indications in ChinaTinea VersicolorTinea PedisTinea +[4
Original Approved Country/TerritoryUnited States
Original Approved Date1981/06/12
Country/TerritoryBelizeUnited StatesPoland +[11
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active IndicationsCushing SyndromeDermatitis, SeborrheicDandruff +[9
Inactive IndicationsHip FracturesPsoriasisAcne Vulgaris +[14

Other Information

ATC CodeD01AC08G01AF11J02AB02